Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials
| Image |  |
|---|---|
| Description | scientific article published on 18 July 2016 |
| Author/s |
author: Peter Buggisch Markus Cornberg |
| Publication date | July 18, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |